Friday, 28 December 2012

"Trojan-horse" therapy eliminates cancer

According to researchers in the UK, an experimental cancer therapy has completely eliminated prostate cancer in experiments on mice.

The "Trojan-horse" therapy is so called because it works by hiding cancer-killing viruses inside the immune system. The viruses are then able to sneak into the tumour, and once inside, tens of thousands of viruses are released to kill the cancerous cells.

Using viruses to destroy rapidly growing rumours is an emerging field in cancer therapy, but one of the challenges is getting the viruses deep inside the tumour where they can do the damage. The team involved in the experiment, led by Prof. Claire Lewis from the University of Sheffield, used white blood cells to deliver the virus into the cells.

After chemotherapy or radiotherapy is used to treat cancer, there is damage to the tissue. This causes a surge in white blood cells, which swamp the area to repair the damage; the therapy makes use of this by "piggy-backing" the virus onto the white blood cells.

In the experiment the team took blood samples from the mice before extracting macrophages and mixing them with a virus. The mice were then given a course of chemotherapy and two days after they were injected with the white blood cells. At the time of injection each cell contained just a couple of viruses, but 12 hours later the macrophages burst and eject up to 10,000 viruses each; these then go on to infect and kill the cancerous cells.

At the end of the 40-day study, all the mice who received the treatment were still alive and showed no signs of tumours. Prof. Lewis now hopes to begin human trials next year and says: "If this treatment goes on to be successful in human trials, it could mark substantial progress in finding better treatments for men with prostate cancer which has spread to the bone." There is however need for caution as many remarkable advances in treating mice have failed to have any effect in people.

Jack

Friday, 21 December 2012

Alzheimer's disease treated by blocking immune response

Researchers from the German Center for Neurodegenerative Diseases, DZNE, as well as the University of Bonn, have discovered that the protein complex NLRP3 is a critical factor in the development of Alzheimer's disease.

The researchers studied the complex "NLRP3 inflammasome" which is already known to have a very important role in the immune system. Its activation means that immune cells are mobilised and inflammation-causing substances can be released.

Alzheimer's disease occurs when plaques begin forming in the brain, which then activate the NLRP3 inflammasome. The researchers in this study looked at the effects that its increased activity has on the brain.

Prof. Michael Heneka and his team studied the brains of dead Alzheimer's patients and mice with disorders that are related to Alzheimer's disease. It was found that the NLRP3 was active in both the humans and the mice. The researchers believed that by suppressing the inflammatory reactions of the protein complex there would be a reduction in the damaging plaques. They then removed the genes that activates NLRP3 inflammasome activity in another group of mice, which meant they were no longer able to synthesise the protein complex. The result of this was that they only showed mild symptoms of Alzheimer's-associated disorders.

This research could result in pharmaceuticals being developed to target the protein complex and inhibit its activity, and the team are already looking for potential ways to block the inflammasome. Prof. Heneka commented: "The testing of potential substances in the laboratory would be a next step. We hope to start as early as next year."

Jack

Friday, 14 December 2012

Child's leukaemia cured by re-engineered immune cells

A seven-year-old girl in the US with an aggressive form of childhood leukaemia has been cured using her own re-engineered immune cells, thanks to an experimental new therapy. Once the treatment had been carried out, the girls's doctors could find no evidence of any remaining cancer.

The girl, Emily, was the first child patient on a clinical trial that is testing T cell therapy to treat acute lymphoblastic leukaemia, as well as other B cell cancers. B cells are the type of White blood cell that becomes cancerous in some leukaemias and lymphomas.

In the trial, known as CTL019, Emily received a custom-designed version of her own T cells, which then rapidly multiplied and destroyed the leukaemia cells. The T cells, which do the job of recognising and attacking invading pathogens, were taken from the girl before being genetically modified by the researchers. They were modified to express a protein that binds to a target called CD19, a protein found on the surface of all B cells, including the cancerous ones. Normally, B cells are capable of remaining undetected by T cells, but the genetic modification makes them able to detect and destroy the cancerous B cells.

The modified T cells were then put back into the patient where they disperse and go in search of cancerous B cells. They also multiply at a rate that allows them to stay on top of the rapidly-dividing cancer cells, and stay in the body to continue fighting any new cancerous cells.

The team hopes that CTL019 will prove an effective therapy for patients with B cell cancers, but because only 12 patients took part in the trial, more adult and paediatric patients need to be enrolled to see if the same results are seen in a larger group.

Jack

Saturday, 8 December 2012

Increase in cancer survival

According to figures from the Office for National Statistics, fewer people in the UK are dying from cancer, despite an increase in the number of people being diagnosed. An analysis of data from 2008-10 shows that there are nearly 323,000 cancer diagnoses each year, and 156,200 patients died in each of those years.

The data also showed that for 2001-03 there were 403 new cancer cases for every 100,000 men and 343 for every 100,000 women. The 2008-10 analysis then showed that these figures increased to 431 per 100,000 men and 375 per 100,000 women.

In addition it was shown that, between 2001-03 and 2008-10, the number of deaths decreased from 229 to 204 per 100,000 men, and 161 to 149 per 100,000 women.

The head of statistical information at Cancer Research UK, Catherine Thomson, said: "While overall cancer incidence rates have continued to rise, death rates have fallen - by 11% for men and 7.5% for women since the start of the century."

This means that each individual's risk of dying from the disease has fallen, which has been helped hugely by the reduction in people smoking, as well as an improvement in the ability to diagnose it. Another factor is the progress that has been made in chemotherapy, radiotherapy and surgery, and the development of personalised medicine.

Jack

Friday, 30 November 2012

New mechanism for cancer progression discovered

The protein called Ras plays an important role in the control of cellular growth. Researchers have focused on this protein because mutations in its gene are found in over 30% of all cancers, making it the most prevalent human oncogene.

However, researchers from Harvard and the University of North Carolina Lineberger Comprehensive Cancer Center have discovered an alternative mechanism for activating Ras; this new way does not require mutation or hormonal stimulus. In healthy cells, Ras transmits hormone signals that prompt cell growth and the development of organs and tissues, but if a mutation occurs these signals can become chronically activated, leading to tumour initiation and progression.

In an article published by Nature Structural and Molecular Biology, the UNC and Harvard teams discovered that it is possible to lock Ras into an active signalling state. They did this by modifying Ras at a specific site with a single small protein called ubiquitin, a process known as monoubiquitination, in which the action of another protein, known as the GTPase activating protein, is disrupted.

Because of the strong link between Ras and cancer, it should be an attractive target for drug therapies, but despite considerable efforts to develop treatments that target the protein, it is now considered to be 'undruggable'. The researchers next step then will be to gain a better understanding of its role in cancer progression, firstly using cells then moving on to animals and eventually cancer patients.

Jack

Friday, 23 November 2012

Mutant cells increase cancer risk

According to new research from USC, certain mutated cells in cancer patients keep trying to replicate their DNA with disastrous results, even when the materials required to do so have been taken away by medication.

The team that carried out the study used a common chemotherapy drug to put stress on fission yeast cells while they were undergoing DNA replication, it works by starving the cells of nucleotides which are used to build DNA strands.

New imaging techniques have shown that while chemotherapy shuts down the DNA replication of most cancer cells, so-called "checkpoint mutants" continue to create damaged DNA strands that can result in cancer-like abnormalities. Older methods suggested these mutants stopped replicating and the replication machinery simply fell apart, but the new technique shows the processes continue and actively contribute to the damage.

It has also been shown in previous studies that normal cells recognise the loss of nucleotides and stop trying to replicate their DNA. However the researchers found that the checkpoint mutants ignore the signal to do this. They continue to replicate their DNA, unwinding the strands, until the DNA strands reach a "collapse point" where they break, this is arguably the worst kind of damage that can be done to a cell.

The next step after this study will be to find out what happens to the small number of cells that survive this treatment.

Jack

Friday, 16 November 2012

Rare mutation linked to Alzheimer's

Two separate studies published online this week, by the New England Journal of Medicine, both point to a link between Alzheimer's disease and a rare gene mutation. The mutation in question is known to affect the immune system's response to inflammation. This discovery supports an emerging theory about the role played by the immune system in the development of Alzheimer's disease.

One of the teams was led by John Hardy of University College London, and the other led by the Iceland-based global company deCode Genetics.

Both teams concluded that a rare mutation in a gene called TREM2, which helps to trigger immune system responses, increases the risk of developing Alzheimer's disease. One of the studies suggests it raises the risk by three times, the other says four. The lead author of the UCL study, Rita Guerreiro, commented: "While the genetic mutation we found is extremely rare, its effect on the immune system is a strong indicator that this system may be a key player in the disease."

In the UCL-led study, researchers from 44 institutions from around the world analysed data from a total of 25,000 people. They used new sequencing techniques to home in on the TREM2 gene, and then used more sequencing to identify a set of rare mutations. They then discovered that the mutations were more prevalent in the 1,092 Alzheimer's patients than in the 1,107 healthy controls. The co-author, Minerva Carrasquillo, said "In our series, it was present in 1.9 percent of the Alzheimer's patients and in only 0.37 percent of the controls."

Also the CEO and co-founder of deCode Genetics said: "The discovery of variant TREM2 is important because it confers high risk for Alzheimer's and because the gene's normal biological function has been shown to reduce immune response that may contribute to the disease." He went on to say that these factors make TREM2 an attractive target for drug development.

Jack

Friday, 9 November 2012

Gene-expression switches play major role in cancer

Scientists from the Karolinska Institutet in Sweden and the University of Helsinki in Finland have shown that the 'switches' which regulate gene expression play a major role in the development of cancer. In a study that was published in the journal Science they investigated a variant of nucleotide that is associated with an increased risk of colorectal and prostate cancer. They also found that removing the DNA region where the nucleotide is found caused dramatic resistance to tumour formation.

Various other studies have discovered genomic regions similar to this that are associated with over 200 diseases, including heart disease, diabetes and different types of cancer. This has attracted much attention from both scientific and popular press but the mechanisms by which these genomic regions act are not fully understood.

In the study the scientists removed the gene region containing the nucleotide variant from the mouse genome, they found that as a result the mice were healthy but also showed a small decrease in the expression of a nearby cancer gene, called MYC. But although the decrease was only small they showed dramatic resistance to tumour formation when tested. This shows then that the gene region that was removed acts as an important pro-cancer gene switch, and removing it causes tumours to develop much more rarely.

According to the scientists, the results show that although the gene variants, which make individual humans different from each other, generally have a small impact on diseases development, the gene switches in which they reside can play a major role. Therefore this technique seems to have potential for cancer prevention in future.

Jack

Friday, 2 November 2012

First gene therapy backed by Europe

For the first time a treatment that corrects errors in a person's genetic code has been approved for commercial use in Europe.

The field of gene therapy has a simple aim, to correct the genetic code of people with genetic conditions, but it has been plagued with problems over the years. Some patients have developed leukaemia and in one US trial a teenage patient died.

Glybera, which is a gene therapy for a rare disease that leaves people unable to properly digest fats, has been given marketing authorisation by the European Commission. This means that it can be sold throughout the EU and the manufacturers, UniQure, say it will become available next year. Lipoprotein lipase deficiency, the disease in question, means that fat build-ups develop in the blood causing abdominal pain and life-threatening pancreatitis. At the moment the only way to manage the condition is by having a very low-fat diet. The new treatment works, as does every other gene therapy treatment, by using a virus to infect muscle cells with a working copy of the gene.

The CEO of UniQure, Jorn Aldag, said: "The final approval of Glybera from the European Commission marks a major step forward in making gene therapies available not only for lipoprotein lipase deficiency, but also for a large number of rare diseases with a very high unmet medical need." Also the company said it planned to apply for regulatory approval in the US and Canada, allowing the treatment to be given to more sufferers of the disease.

Hopefully this will now spur on more research into gene therapy and lead to new treatments that can treat a variety of genetic diseases, without the troubling side effects that have been seen in the past.

Jack

Friday, 26 October 2012

Progress in Epigenetic code

A group of researchers from the Australian National University has discovered how Epigenetic information is transmitted from one generation of cells to the next.

Epigenetics, a new frontier of genetic science, is the additional layer of genetic information which controls the expression of genes. It determines which of the 20,000 genes come into play, in order to ensure the right genes are expressed in the correct cell type.

The study focused on how Epigenetic information is restored following the cellular division of stem cells, a process that is essential for their renewal. The lead researcher in the study, Dr David Tremethick from The John Curtin School of Medical Research, said developing a better understanding of Epigenetic processes has significant potential implications for human health, including the treatment and prevention of cancer.

Using mouse stem cells as a model it was discovered that inheritance of Epigenetic information is much more dynamic and unstable than expected. This instability has both positive and negative consequences because on one hand there is the possibility of information being corrupted, but on the other it provides the potential to intervene in the process, and correct corrupted information.

Te next step will be to understand how Epigenetic information is naturally altered to allow the transition from a stem cell to a specialised cell, the process that takes place during embryonic development. This will then provide a better understanding of how inheritance goes wrong in diseases such as cancer, and possibly lead to improved treatments and preventative measures.

Jack

Friday, 19 October 2012

Vitamins lower risk of male cancer?

US researchers have claimed that taking a multivitamin pill once a day could lower the risk of men developing cancer.

The study they conducted, which was carried out for over a decade, involved 15,000 men over the age of 50, including a control group who were given a sugar pill placebo.

The findings of the study, that were published in the Journal of the American Medical Association, report that there was a small reduction in cases of cancer among the men who took the multivitamin pill. However, experts advise that a diet including plenty of fruit and veg is a better option, since other studies have shown that multivitamin pills do more harm than good, and some say they have no beneficial effects on cancer.

Despite being recommended for some groups of people, for example vitamin D is recommended for the over 65s, the reported effects of multivitamins on general health are mixed.

Out of every 1,000 people who took the multivitamin pill there were 17 cancers per year and of every 1,000 who took the placebo there were 18 per year. Dr Helga Groll, from Cancer Research UK, said "Although this study suggests that men in the trial had a slightly lower cancer risk if they took multivitamins, we can't be sure from this research whether this is a true effect or down to chance."

It seems then that the best course of action is to have a healthy diet that includes a variety of fruit and vegetables, and to only rely on multivitamins to any extent if it is advised by your doctor.

Jack

Friday, 12 October 2012

Nobel prize awarded for stem cell work

Two pioneers of stem cell research, John Gurdon and Shinya Yamamaka, have jointly won the Nobel prize for medicine or physiology for turning adult cells into stem cells. Prof Gurdon from the UK used a gut sample to clone frogs and Prof Yamanaka from Japan altered genes to reprogramme cells.

The Nobel committee said the discoveries made by the two men had "provided new tools for scientists around the world and led to remarkable progress in many areas of medicine." The pair were also described as having "revolutionised" science as well as our understanding of how cells and organisms develop.

In 1962 John Gurdon made his discovery when he showed that genetic material inside a frog's intestinal cell contained all the information required to create a new frog. He removed the genetic information before placing it into an unfertilised frog egg and the clone developed into a normal tadpole. This technique of transferring the genetic information eventually gave rise to dolly the sheep, the first cloned mammal.

Forty years after Gurdon's discovery Shinya Yamanaka devised a different approach. Rather than transferring the genetic information into an egg cell he reset the cell, adding genes that turned a body cell back into a stem cell. Four genes were added to skin cells which then transformed into stem cells and were able to become any type of specialised cell.

One of the long-term goals of the techniques is to be able to use a sample of a person's skin to create stem cells that are specifically tailored to them. These cells could then be used for various things such as treating Alzheimer's disease or repairing damage caused by a heart attack.

Jack

Friday, 5 October 2012

'Skin-cell-mice' become parents

In experiments carried out by a team of scientists from Kyoto University, which were documented in the journal Science, a sample of skin cells taken from a mouse was used to produce stem cells which were then made into egg cells. These eggs were then fertilised with mouse sperm to produce baby mice and later on they were even able to become parents themselves, showing their origins had no adverse effects on their fertility. The feat comes just a year after scientists from the same university carried out a similar procedure in which they produced healthy sperm cells.

If it can be adapted for people the technique could help infertile couples to have children and allow women to overcome the menopause, provided the scientific and ethical barriers holding it back can be overcome.

After acquiring the stem cells the next step in the procedure was to turn them into early forms of egg cells, however in order for them to develop into mature eggs a "reconstituted ovary" was built from various types of supporting cells and then transplanted into a female mouse so they had time to mature. Once the eggs were fully developed they were removed from the female using standard IVF techniques and were fertilised with sperm from a male mouse, before being implanted into a surrogate mother.

Therefore this technique could be used to help infertile couples have children by creating gametes artificially from other cells in their body, the resulting child would then be genetically related to it's parents just as any normal child would.

Despite this Dr Katsuhiko Hayashi, from Kyoto University, said that it was still a distant prospect because "it is impossible to adapt immediately this system to human stem cells, due to a number of not only scientific reasons, but also ethical reasons." The reasons for this are that knowledge of human egg development is still very limited and there would be questions about the long-term health of any child born as a result of this procedure.

In my own opinion if the technique can one day be made to work effectively for humans and the child's good health can be assured it will be a remarkable step forward in fertility treatment. I think this because the production of gametes (which is a relatively small part of the reproductive process but has huge effects if it happens incorrectly) can be carried out by science if need be but the rest of the child's development takes place as normal, since the fertilised embryo would soon be placed into the mother's womb to develop naturally.

Jack

Friday, 28 September 2012

Scarless healing in mice

According to US researchers mice may offer clues to how skin can heal without scarring.

In a study a group of African spiny mice lost up to 60% of the skin from their backs but unlike other mammals instead of forming a scar the skin rapidly healed and even regrew hairs. Scientists now want to find out how the healing takes place and if it can be applied to people in regenerative medicine.

Other creatures such as salamanders are famous for their regenerative abilities as they can regrow entire limbs if lost, and this has encouraged researchers to focus their efforts on reproducing this effect in humans. At the moment mammals have only very limited regeneration abilities so if a limb is lost scar tissue forms to prevent blood loss and infection, but the limb does not grow back.

However it seems that mammals have greater regenerative capabilities than they are given credit for since not only were these mice able to rapidly heal skin tissue, but they were also able to heal large circular holes punched in their ears. To do this required regenerating multiple tissues including hair follicles, sweat glands and cartilage. Tests performed on the mice showed that when injured they formed a blastema which acts as a 'regenerative hub', a bundle of stem cells similar to what is used by salamanders to regenerate whole llimbs.

Dr Ashley Seifert from the University of Florida said "It is thought that one of the main constraints on regenerating appendages in humans, or mammals for that fact, is the failure to form a blastema." Research continues however into how stem cells in organisms such as salamanders are able to regenerate different tissue types, allowing a new limb to form. It may even be possible in the future to regrow entire human limbs for use in medical treatments, if a way to form a blastema can be found, and I would be thrilled to contribute to some of the research that makes it possible.

Jack

Friday, 21 September 2012

3D map shows brain blueprint

A 3D 'map' created by a team from the Allen Institute for Brain Science in Seattle and Edinburgh university, has shown that all human brains are very similar as they have the same molecular blueprint.

The map was made by analysing about 900 parts of 3 brains and includes the measurements of over 100 million gene expressions; in the study the brains were cut into tiny pieces and using computer software scientists painstakingly analysed each piece, allowing them to work out the pattern of gene expression in each brain. One potential benefit of a project like this is that it could help us understand how brain disease is caused by genetic disorders.

Before this project the researchers had spent years performing similar experiments on mice but since the human brain is a lot more complex they had to alter their approach to achieve the best results.

In the study it was found that the majority of the genes in the human brain are expressed in very similar patterns to each other, showing our brains are very similar despite having different personalities.

Prof Ed Lein, a member of the research team, said the 'atlas' they made could provide vital information in our general understanding of how brains function and develop, as well as how they evolved and are affected by disease. Prof Seth Grant of Edinburgh university also added that another objective was to produce a map in a format that could be used by scientists studying completely different brain-related issues, thus aiding future research in this field.

Jack

Friday, 14 September 2012

Stem cell treatment for deafness

Researchers in the US have made a huge step forward in treating deafness after stem cells were used to restore hearing in animals for the first time.

According to a UK study published in Nature, hearing in gerbils was partially improved when the nerves in their ears were repaired using stem cells to replace the spiral ganglion neurons, the cells that had been damaged and broken the link between the ear and the brain. The improvement made to the gerbils is equivalent to improving a human's hearing so they go from being unable to hear traffic to hearing a conversation.

The stem cells used in the study were taken from a human embryo and a "chemical soup" was then added to convert them into cells similar to spiral ganglion neurons, before being injected into the inner ear.

Using equipment to monitor their brainwaves, it was found that about a third of the 18 gerbils responded very well to the treatment, with some regaining up to 90% of their hearing, and just under a third barely responded at all.

However there are some drawbacks to the research as well as the treatment itself, for example only 18 gerbils were treated which is quite a small sample and their brainwaves were only tested for 10 weeks. As well as this the inner ear is very difficult to access which would make treating humans with the technique very difficult. Because of this it will likely be a while before deaf people can be treated using stem cells.

Jack

Friday, 7 September 2012

Detailed genome map

Recently scientists have published the most up to date map that details the function of the human genome, in research carried out by over 400 scientists in 32 separate laboratories.

They used to think that only a small section of our genetic code is biologically active but the researchers have now discovered it is actually a much larger chunk. In fact 80% of our genome has a specific function to perform, with a much smaller amount of "junk DNA" that has no proper function. It is thought the research could deepen our understanding of certain diseases and produce better treatments for them.

As well as discovering what proteins were coded for by the DNA, four million gene switches were also identified which control what genes are switched on or off in cells. Dr Ewan Barney, from the European Bioinformatics Institute in Cambridge, commented "This will help in understanding of human biology. Many of the switches we have identified are linked to changes in risk for conditions from heart disease to diabetes or mental illness."

Another scientist, Dr Ian Dunham, said the data could ultimately be of help in every area of disease research but scientists acknowledge it is likely to be many years before patients see tangible benefits from the project.

Jack

Friday, 31 August 2012

Lifetime hip replacements

A team of biologists, nanoengineers and surgeons from Glasgow University has come up with a technique that could produce hip replacements that last a lifetime. At the moment a patient is lucky if their replacement lasts 15 years because it wears away so quickly, especially now more younger patients are receiving them who tend to be more active.

The researchers made the discovery that by controlling the pattern on the surface of the joint they could control what type of tissue forms there. This means it would be possible to encourage stem cells to form new bone in contact with the joint by coating the key surfaces in a "nanopattern" pitted plastic. This system aims to avoid the problem of soft tissues forming around the hip replacements which can cause them to come loose, instead the bone that forms will prevent this problem by keeping a much tighter grip on the joint.

The next step would be to coat the key surfaces of an implant with the pattern and carry out some human trials, this means it will likely be five or maybe ten years before the technology is used in the operating theatre. However it should be well worth the wait as it could also be useful in knee and shoulder replacements, and the nanopattern may even have applications in new drugs to combat osteoporosis.

Jack

Saturday, 25 August 2012

Drug can 'disarm' harmful bacteria

Researchers at the University of Montreal have discovered a way to 'disarm' hostile bacteria which then allows the body's own immune system to destroy them as an alternative to killing the bacteria outright with antibiotics.

Dr. Christian Baron, Professor at the Department of Biochemistry, said that the drug they had developed would remove the bacteria's virulence factors (the things that make some bacteria harmful to us) therefore rendering them harmless and vulnerable to attack from our immune system.

The finding came about during their research into a type of pathogenic bacteria called Brucella when Baron's team discovered small molecules that target proteins in a biological system which are required for many bacteria to be harmful.

This method of killing bacteria to stop infection in patients is welcome news as nowadays there are many forms of antibiotic resistant bacteria that evolved as a result of antibiotic overuse. However if these anti-virulence drugs become widely used in place of antibiotics they should not lose their effectiveness just as antibiotics did, Dr. Baron claims that the development of resistance to them would be slow or might not even occur at all. In addition to this we now understand how resistant bacteria can come about so we can prevent resistance to this type of drug by only prescribing them when they are really necessary.

Unfortunately no human trials on anti-virulence drugs have yet been carried out so it will be a while before they become widely available and doctors are able to prescribe them to patients.

Jack

Friday, 17 August 2012

AS Results

Yesterday morning like many other anxious 17 year olds across the country I received my AS results which will help to determine what I'll go on to do next year.

Naturally I was pleased to find out that I'd achieved ABBB in Maths, Chemistry, Human Biology and Psychology respectively. If I'm able to replicate this success in a year's time with my A level results for Maths, Chemistry and Human Biology (as I intend to drop Psychology) I should be in a good position to get on a Biochemistry course.

I also hope to increase my Human Biology grade to an A which will mean I'll meet the requirements for a wider range of universities and give me an even greater choice of where I study. But at the moment even ABBb equates to 370 UCAS points which is more than enough for some of the universities I've looked at, and I can add onto that the points I get for completing the Extended Project Qualification, provided the University recognises it.

For now though I'll continue preparing my UCAS application and looking into some more universities that I haven't considered yet before I decide which five to apply to.

Jack

Thursday, 16 August 2012

Prostate drug approved in Scotland

Abiraterone, a drug that can extend the lives of men with incurable prostate cancer, has been approved for use in Scotland, the last part of the UK to make it available on the NHS.

The disease, which kills 10,000 men a year, is the second most common cause of cancer deaths in UK men.

The Scottish Medicines Consortium (SMC) had previously rejected a submission to allow the drug to be used in Scotland as they believed the cost of £3,000 a month did not justify the health benefits. However after reversing it's initial decision the SMC has decided to restrict the drug to patients who have only received one chemotherapy regime.

The verdict has been welcomed by cancer charities such as Prostate Cancer UK whose chief executive, Owen Sharp, was pleased at the decision. He said "Today brings a victory for both decency and common sense. Abiraterone has now been approved for use on the NHS UK-wide and I thank and congratulate everyone who backed us and helped us achieve this result." Also Dr Harpal Kumar, chief executive at Cancer Research UK, commented that although Abiraterone is not a cure, it can provide men with crucial extra months at the end of their lives.

Now that doctors across the whole of the UK are able to prescribe the drug to men with prostate cancer, it can give hope to sufferers of the disease by giving them the time to do what they want before they die.

Jack

Friday, 3 August 2012

'Spray-on-skin' heals wounds

According to US and Canadian researchers a "spray-on-skin" that coats wounds in a layer of skin cells and blood-clotting proteins could help the healing process.

A study was conducted on 228 people suffering from leg ulcers, painful open wounds that can last for months, and it was found that the ulcers which were treated with the spray had a higher chance of healing, and those that did took less time to do so.

If this treatment became widely available it would be a welcome break to those who suffer from leg ulcers as it was found to be more effective than other treatments including the current most effective, compression bandages, and skin grafts that are taken from other areas of the patient's body. 70% of those treated with the spray were healed after 3 months compared to 46% of the people who received other treatments, and the biggest improvements were in the patients who were given the spray every 14 days.

The treatment would also be preferable to skin grafting as the spray can be available to use whenever needed, whereas skin grafts take time to create which puts the patients in more discomfort and leaves them vulnerable to infection. As well as this the fact that no skin needs to be taken from the patient means they won't be left with a scar on another part of their body.

Although this treatment does not address the underlying cause of leg ulcers so they are not prevented from happening again, it does improve short-term healing which in my mind justifies the cost.

Jack

Friday, 20 July 2012

Polypill could reduce heart attacks and strokes

According to researchers a new pill that combines statin with blood pressure drugs could prevent thousands of heart attacks and strokes every year.

The pill consists of a statin and three blood pressure drugs that are already widely used and although the British Heart Foundation said that pills were not a substitute for a healthy lifestyle the researchers called for it to be made available as a matter of urgency.

In the experiment, which was carried out on 84 people over the age of 50, the patients were given either the polypill or a placebo once a day for three months and then their treatments were swapped so that every patient spent three months taking the real pill and three months taking the placebo.

The results if the study showed that the pill gave a 12% reduction in blood pressure and decreased levels of LDL cholesterol by as much as 39%. Dr David Wald, a consultant cardiologist working on the pill, said the health implications of their results were large and that if people took the pill from the age of 50 an estimated 28% would benefit by having a heart attack or stroke delayed or avoided in their lifetime. In other words, if half of the UK over-50 population took the daily pill it would prevent 94,000 heart attacks and strokes a year.

However this was only a very small study using just 84 participants so a lot more research would be needed before the pill can be rolled out, this would be to ensure there are no side effects and it is just as effective in treating the wider population.

Jack

Friday, 13 July 2012

Nottingham Summer School

This morning I got back from Nottingham after a great week of learning about life at university and taking part in some academic sessions.

I was on the Veterinary Medicine and Biosciences strand so I spent Monday and Tuesday learning about Veterinary medicine and Wednesday and Thursday learning about Biosciences such as Plant Science, Food Science and Environmental Biology.

One of my favourite sessions was the trip to the dairy farm near the Sutton Bonnington campus as we discovered how technology is being used to improve yield and animal welfare and the research that is being done there. One thing that stood out was the huge robot arm that milks the cows, I found this particularly interesting as it's able to recognise each individual cow via a transponder around their neck so each cow is only milked a certain number of times a day.

As well as this I learnt about the research into biofuels that was being carried out on the cow slurry and the experiment to see how diet affects the cows' methane production.

I also took part in some team building exercises which I found very effective and a session on personal statements which gave some really good advice.

So overall the summer school was a great experience and I've learnt a lot more about what studying at university is like.

Jack

Friday, 6 July 2012

Robot legs are best yet

US experts writing in the journal of neural engineering have developed what they describe as the most biologically-accurate legs to date.

Unlike previous robotic legs this pair also mimics the way that legs are controlled, not just the way they move. The team, from the University of Arizona, replicated the central pattern generator (a neuronal network in the lumbar region of the spinal cord) that generates rhythmic muscle signals.

The researchers hope to use the legs to learn more about spinal-injury treatment and how babies learn to walk. They have already suggested that babies start off with a simplistic setup in which their CPG consists of just two neurons that fire signals alternately, as well as sensors that deliver environmental information back to the centre.

The research could also be used to increase understanding if patients with spinal cord injuries and may lead to better prosthetics further down the line.

Jack


Friday, 29 June 2012

Four-in-one HIV pill simplifies treatment

A new pill that combines four HIV drugs has been confirmed as safe and effective according to a new US study. The "quad pill" should make it easier for patients to stick to their medication and will improve its overall effect as they will be more likely to take it when they can replace four separate pills with just a single one.

Although the HIV virus is incurable it can be controlled with a combination of drugs taken at different times of the day, but if the patient forgets to take them their body could lose the fight against the virus.

Paul Sax, associate professor at Harvard Medical School, carried out the research in question in which he compared the quad pill with the current best treatment in 700 patients. He found that it was as safe and effective as the current treatment but with a higher level of kidney problems among those taking it. Even if this is down to the pill it is still a viable treatment option as the risk of kidney problems will likely be less than the risk of what would happen if they forgot their medication.

This pill shows how much HIV treatment has advanced since the time when patients were taking up to 40 pills three times a day and is great news for HIV sufferers as it increases options for the way they are treated.

Jack

Friday, 22 June 2012

Foetus saved by pioneering tumour op

At her 17-week scan mother-to-be Tammy Gonzalez said she could see what she described as 'a bubble' coming out of her baby's mouth which in fact turned out to be an oral tumour. Doctors then told her there was very little chance the foetus would survive yet today her daughter, whom she called Leyna, is a perfectly healthy 20-month-old child.

The "oral teteroma" which has only been seen once in 20 years at the Jackson Memorial Hospital in Florida was removed by doctors even though it was a 'world first' operation.

During the procedure Mrs Gonzalez was put under a local anaesthetic before having a needle pushed through the protective amniotic sac around the foetus, the tumour was then cut from Leyna's lips in the operation which lasted just over an hour leaving only a tiny scar on her mouth.

As far as the doctors are aware this is the first successful treatment of foetal oral teteroma in utero and the story of the operation only came to light when it was reported in the journal of Obstetrics and

Jack

Friday, 15 June 2012

Ten-year-old gets lab-grown vein

Swedish doctors report that a ten-year-old girl, who had poor blood flow between her intestines and liver, received a new vein that was grown with her own stem cells.

The girl had a blockage in her original vein which could have caused internal bleeding or even death, and after other treatments such as bypass surgery failed this became the best option.

The replacement vein was taken from a dead man before having it's cells stripped off in a process called decellularisation in which repeated cycles of enzymes and detergents destroyed and washed away the donor's cells.

The 'scaffold' that is left behind was then bathed in the girl's own stem cells from her bone marrow producing a vein made of her own cells that won't be rejected by her immune system. The procedure then led to a 'striking' improvement in her quality of life according to the surgeon who performed the operation.

Jack

Friday, 8 June 2012

A cure for HIV?

A cure for HIV has been much sought after by scientists and medical professionals but it has been deemed impossible as the virus mutates so rapidly, this means that after a relatively short period of time the antigens on it's surface have changed and it has become virtually unrecognisable.

However one HIV expert, Francoise Barre-Sinoussi, believes finding a cure might be possible but she could not put a timescale on it, and her word on the matter should be taken seriously as she won a nobel prize for her work on identifying it in 1981.

This renewed hope comes after the experiences of two patients who suffer from the disease. One of them was apparently able to clear his infection through arduous bone marrow transplants and the other was not cured but his body was able to briefly control the virus without the need for antiviral drugs after a much simpler gene therapy procedure.

Both of these 'cures' are good alternatives to the current life-long treatment of antiviral drugs as the patient only has to be treated once and the antiviral drugs are not as readily available in some of the poorer countries that have a particularly high prevalence of HIV, such as sub-saharan Africa.

So one day we may be able to wipe out HIV which has killed at least 30 million people since 1981 and confine it to the history books just as we did with smallpox.

Jack

Friday, 1 June 2012

Lung cleaning improves transplant viability

This week scientists at Newcastle University pioneered a new technique called ex-vivo lung perfusion to clean lungs and make them more suitable for transplantation.

At the moment only one in five donated lungs are good enough to be transplanted which us often because the cause of the donor's death also damages them, however their condition can be improved using a modified heart-lung bypass machine to pump air into the lungs and nutrients through the blood vessels.

Doing this helps to clear any water on the lungs and can be used to treat any infection, according to Professor Andrew Fisher who led the trial this may double the number of lungs that can be transplanted.

The procedure won't undo permanent damage from things such as emphysema but it will still be effective on a lot of lungs that aren't functioning as well as they should be.

This is probably one of the last improvements to make to transplantation as the surgery and immunosuppressant drugs have already been "mastered" to a high enough level.

It will also mean that patients who require lung transplants will not have to suffer as much from the agony of going in to theatre and being prepped for surgery only to be told the lungs are unsuitable, such as the many cystic fibrosis sufferers who require this surgery.

As long as there are no infections from the procedure it can soon be carried out nationwide and will shorten the transplant waiting list making it easier for the NHS as well as the patients.

Jack

Friday, 25 May 2012

Male contraception gene

Just today BBC News published an article on a study which found a gene in mice that could act as a contraceptive, if applied to humans it could lead to an alternative to condoms or vasectomies by causing temporary infertility.

The researchers from Edinburgh randomly altered the genetic code of a group of mice and found that some of them became infertile, they then discovered the gene called Katnal1 which results in healthy sperm development. However when Katnal1 is modified the sperm do not fully form since it contains the blueprints for a protein which is important in cells that support the development if sperm.

Because the gene is responsible for sperm in the late stage of development a drug that interrupted it's action would not leave lasting effects such as permanent infertility.

Dr. Lee Smith, one of the researchers, said it was important to make a non-hormonal contraceptive for men but it would be difficult as the protein lives inside cells, however he went on to say that there may be something else that this protein works with which may be a more vulnerable target.

Either way any non-hormonal drug that acts as a contraceptive for men must be very specific for either the sperm or other cells in the testes involved in sperm production, otherwise it could cause damage to other tissues in the body and may potentially be dangerous.

Jack

Friday, 18 May 2012

Universal Blood Compatibility

For the last part of the human biology course we've been learning about blood transfusions and why some people can safely receive any type of blood and some can only receive blood that exactly matches their own.

People with certain blood types have antibodies in their blood that will attack certain types of donated blood cells by binding to the antigens on their surfaces and causing them to agglutinate, or clump together. Whether or not this happens depends on whether the antibodies in the recipient's blood match the antigens on the cells of the donor's blood, both of which are determined by their blood types.

If the wrong type of blood is given to a patient it could have severe consequences so it is very important that there is always a variety of different types stored at hospitals so a patient of any type can receive a transfusion.

However in 2007 an experiment was carried out in which one blood group was turned into another by removing the antigens. The scientists involved removed the antigens on the erythrocytes using an enzyme which they found after a search of 2,500 different types of bacteria and fungi.

Blood group O which they made has no antigens on its surface so the antibodies in the recipient's blood will not attack it and it will be safe to transfuse. This could go some way to helping the current shortage of blood as it will no longer matter if there is not enough of a particular type; they can simply convert it all into group O and then give that to any patient who needs it. Usually the medical staff try to match the blood group exactly just in case but having an extra supply of O type will mean there is always a backup if an exact match cannot be made.

Jack

Thursday, 10 May 2012

Cancer shield for body cells

The early results of a US trial have shown that it may be possible to protect the body from the damaging effects of chemotherapy, which attacks normal body cells as well as cancerous ones. The chemicals used in the treatment attack rapidly dividing cells so they focus mainly on the cancer but can also attack other cells such as the bone marrow which are very susceptible to chemotherapy as they divide rapidly into blood cells.

A study in Science Translational Medicine used genetically modified stem cells to protect the bone marrow from damage, which is a huge achievement as they are needed to make new blood cells. If however the bone marrow is damaged then fewer white blood cells will lead to a higher risk of infection and fewer red blood cells will cause tiredness and shortness of breath.

The scientists removed stem cells from the bone marrow of three brain cancer patients and "infected" them with a gene that made them more resistant to chemotherapy, before putting them back into the patient so they could continue to produce blood cells.

Protecting the bone marrow from the harmful side effects of chemotherapy will mean that the treatment can be used more fully as sometimes it has to be stopped, delayed or reduced because of the damage being done. The results of the study are promising as the patients survived for longer than the average survival time of 12 months, including one who was still alive 34 months after the treatment.

Jack

Friday, 4 May 2012

Eye implant restores vision

In the past few days you may have heard the news story about the two men who received retina implants which partially restored their vision after more than a decade of inactivity.

The 3mm microelectronic chip with 1,500 light-sensitive pixels was inserted behind the retinas of Chris James and Robin Millar and has altered their lives. It sends flashes of light to their brain rather than conventional vision and they can only see in black and white but it is still a huge improvement to their lives and a big step forward in medical science.

The patients have to 'learn' to interpret the signals being sent as electrical impulses along their optic nerve to their brain. Currently they are able to make out shapes at close range which should lead to them being able to recognise people, but their vision could be improved even further as they master the ability to interpret the signals.

A Finnish man who received the same implant in 2010 was able to interpret letters but his only worked in a laboratory setting and was not portable. Hopefully the next step will be to make an improved version that works just as well so the recipients have the ability to read in addition to it being portable

Also scientists could make one that is able to interpret different wavelengths of light, it could then transmit a signal along the optic nerve just like the light-sensitive cells in a fully functioning eye would, and the patient would be able to see in colour.

I think this concept could be a good alternative to stem cell therapy as so far that has only been carried out on people with some residual vision, not those that are completely blind. It also has fewer ethical implications than the use of stem cells but still with good results. I look forward to seeing how things such as this develop in the future and what progress and improvements they are able to make.

Jack

Friday, 27 April 2012

Nottingham Summer School

Just yesterday I got my letter of acceptance for the Nottingham summer school for the Veterinary Medicine and Biosciences strand of the experience programme, it's not my first choice but I should still find it useful and interesting and it has relevance to medicine. I'm looking forward to the activities I'll be taking part in aside from the lectures because this was lacking from Medlink, and having these will give more of an insight into day-to-day university life, in particular I like the sound of the arts and sports activities and the quiz night that are mentioned in the information pack. The lectures at Medlink were all very interesting but they didn't give you much of an idea of what it is really like to live and study there.

Also this week I had a target setting day at school, I went in for an appointment with my form tutor and talked about how to achieve the grades I need to get in my AS exams and also get some medical work experience. She recomended getting a personal tutor to help with my Human Biology and Chemistry which I will think about so I can get an A in both of them. I'm also going to make a CV and send that out to the nearby doctors' surgeries and hospitals to ask them for any work experience they can offer me, the problem I find is that they are reluctant to offer it to people under 18 but I will try regardless, if unsuccessful then I will definitely consider a gap year to improve my chances. If anyone has any advice on how a 16 year old could get medical experience while I'm 16 I'd be very grateful.

Jack

Friday, 20 April 2012

Revision time!/Print your own drugs

AS summer exams are less than 4 weeks away so now its definitely time to be stepping up your revision and doing some hardcore preparation. Past papers seem to work well for me since it gives me practice at recalling the things I've learnt and gets me accustomed to the exam situation, meaning I'm more comfortable when I come to do it for real. Of course its also good at giving you an idea of which things you know well and which you need to go over again and study a bit more just to solidify your knowledge.

So far I've done about 3 or 4 Core 2 Maths papers with pleasing results and I'm halfway through a Human Biology unit 1 paper that I'm doing to practice for my resit, I was somewhat disheartened with the C that I got in January but I took comfort from the fact that the national average was an E.

I also find that writing out definitions onto cuecards works well, especially in subjects like Chemistry where there is a good portion of marks on offer for knowledge of definitions. All you need to do then is carry the cards with you and use them to test yourself when you have a few minutes to spare, just small things like that a few times a day on top of your other studying can really help.

Also this week while I was having a look through the BBC News health section a came across a story about using a 3D printer to create prescription drugs within the patient's home. I know I've done a post similar to this before but it's mind boggling in its suggestion that we may be able to create all sorts of drugs that are only available at the pharmacy with just a common starter material like the ink you would put in a normal printer. One of the researchers goes on to say that the chemicals could be printed inside a housing that you would simply put it in the microwave and they would react in such a way that they formed the specific drug that you require. The work of the researchers from Glasgow University has been published in the journal Nature Chemistry and its definitely worth having a look at the video at http://www.bbc.co.uk/news/uk-scotland-17744314.

Jack

Friday, 13 April 2012

Gap year experience

This week I bought the book 'So you want to be a doctor?' to assist me with planning my journey to medical school and so far I've barely been able to put it down.

A part I've found particularly interesting is the section on taking a gap year and all the things that you can do during it. If you choose to take one you could use it to build up vital work experience in the medical profession which is difficult to get while you're still under the age of 18, and is especially problematic for people like myself with their birthday at the end of the school year.

However spending the whole year working alongside doctors is not the only productive thing you can do, the time can also be well spent on an extra-curricular activity such as learning a musical instrument or taking part in a sport. For example if I choose to take a gap year I intend to continue training in karate, I left my local club after achieving a brown belt and would love to get up to the rank of black belt as well as participate in a few tournaments outside of the training room.

In addition to these a year out of education could be a good opportunity to get a job, full-time or part-time, to gain you more life experience and earn some money to fund your other activities; even just a few hours a week in a shop will show that you're able to work in a team and also get you enough money to pay for those guitar or swimming lessons, or whatever you decide to do.

Most medical schools like the idea of their applicants taking a gap year as all the things you do during it will help to make you a more well-rounded person, so if you take one through choice or find yourself forced into one after rejections from all your applications, its always worth considering doing something worthwhile during it given the benefits in offer.

Also as a final point it might be worth considering doing something abroad with your time off, if you're interested check out www.limxpo.org, they take people over the age of 16 to Romania or India to work on life-changing projects, it will give you a great sense of satisfaction and help you to stand out from the crowd.

Jack

Friday, 6 April 2012

Breast cancer detection

A study published in this Wednesday's edition of the journal of the American medical association found that the use of MRI scans, as well as standard annual mammography, increases the rates of breast cancer detection in women with an increased risk of breast cancer.

The researchers wrote that the use of annual ultrasound screening could also be useful as it could detect small, node-negative breast cancers that are not visible using mammography, and using MRI scans could reveal additional cancers missed by both ultrasound and mammography.

However, after conducting a study on 2,809 women with an increased risk of breast cancer and a median age of 55 (54% of whom had a personal history of the disease) they concluded that the use of MRI scans on women at intermediate risk may not be appropriate. This was due to the high rates of false positives that the screening gave, the additional financial cost and the reduced tolerability of MRI.

This therefore means that the disease will not be caught any earlier than it was before and so treatment for it will be just as difficult, whereas it would have been more successful if detected at an earlier stage, and fewer deaths would have resulted.

Jack

Friday, 30 March 2012

Care during pregnancy

This week in Human Biology we've been learning about how to care for your unborn child during pregnancy and what steps should be taken to minimise the risk of doing harm to it.

When a woman is pregnant it's clearly very important that she takes care of herself and by doing so takes care for her unborn child, to do this it is recommended that she doesn't smoke and drinks as little alcohol as possible.

Smoking during pregnancy can cause a number of problems including oxygen deficiency in the foetus, premature birth and still birth or cot death. The supply of oxygen to the developing baby will be lower because the carbon monoxide permanently binds with the erythrocytes to form carboxyhaemoglobin and the nicotine reduces the diameter of the blood vessels, which also makes the foetus' heart beat faster. Therefore it is very important that a potential mother gives up smoking before trying to get pregnant and does not take it up again after the birth, to protect the health of her child, also passive smoking either from the father or someone else can cause harm both during and after pregnancy.

Drinking alcohol during pregnancy is seen as more socially acceptable than smoking but if the mother does not take care consume it in moderation, then it can lead to problems with the development of speech and language and can affect the child's attention span. The government's recommended alcohol allowance for pregnant women used to be one or two units once or twice a week but they now advise that they stop drinking altogether. Another possible effect of this is that the baby may suffer from heart and face deformities and impaired brain development, known as fetal alcohol syndrome. It is clear then why mothers should take extra special care of their bodies while they are pregnant, by avoiding alcohol, tobacco and any other drugs as well as getting the right nutrition for them and their child.

Jack

Thursday, 22 March 2012

Immunotherapy and cancer

Researchers at the Georgetown Lombardi comprehensive cancer centre say that antibodies which were once considered the 'magic bullets' of cancer treatment are now living up to that expectation.

In an article posted in 'Cell' the researchers say that refinements and modifications of monoclonal antibody drugs are now being tested in most types of tumour. The modifications allow the drugs to attach to more than one target on the cell and to directly stimulate the body's immune response which promotes anti-tumour effects similar to a vaccine. In addition to this some antibodies will lock onto the antigens on the surface of a cancer cell and then a chemical attached to to them will emit beta radiation. This type of radiation emits radiation with a radius of a couple of centimetres so it can destroy an entire tumour but with little collateral damage to the normal surrounding tissue.

After doing some work on this subject in Human Biology I became quite interested in immunotherapy as it is using the body's own natural defences to fight something that is more difficult to attack with artificial means such as chemotherapy and radiotherapy. This is something that I would quite like to do some research into because I think it has the best possibility of leading to a full cure for cancer. One of the drawbacks of this treatment is that the antigens which are needed for it to work are only present on the surfaces of some types of cancer cells, meaning it is only an option in a fraction of cases. However, if that can be worked around, it will be a lot more effective as a treatment and more research into it will be done.

Jack

Friday, 16 March 2012

Oxford University

So on Wednesday I attended the Oxford University study day for the medicine category and learnt a bit about the Oxford selection process. They focus a lot more on grades than other universities and are more concerned about you having a real interest on your chosen subject than you doing lots of things outside education. The entry process includes between 1 and 3 20-40 minute interviews which is more than other universities but the content is different. Rather than asking you about your hobbies and interests they will quiz you on the subject you are applying for to test your knowledge of it outside of what you've been taught. It is therefore very important to read up on the subject in your free time and make good use of other information sources.

Also this week I read about how scientists in Sweden are beginning to create human corneas from stem cells which could eventually lead to having no need for cornea donors. This leads on from what I wrote last week as at the moment a cornea transplant is the only way to save the eyesight of someone who has damaged there's, but receiving this treatment could mean that their eyesight is restored without the need for a cadaver. Donations of things like corneas are obviously harder to come by than other organs/ tissue because it cannot be done while you are alive, meaning people who need them have to wait a long time.

Jack

Friday, 9 March 2012

Tissue donation

This week we had a talk from someone from the Anthony Nolan trust about donating blood, bone marrow and organs. It reminded me of the critical shortage of these things that the health service faces and made me think that we should all probably do a bit more to help out.

90% of all people say that they would accept an organ transplant if they needed one but only 27% are actually on the organ donor register, meaning that every day three people die whilst waiting for a transplant. Of course one day it may be possible to grow a limitless amount of organs so we will no longer require donors but right now we can't do that and it is important we address that issue.

Signing up to donate organs is probably the easiest one as it is most likely that they will only be taken after your death, but it is possible for an adult to donate a kidney or a small piece of liver whilst they are still alive. If you are considering it you will need to talk to your parents about it as you need to keep them informed and respect their wishes as well.

Blood donation requires a lot more commitment than organ donation as once you sign up it is possible to donate every four months from the age of 17 to 65. There are a lot of misconceptions about this being a painful procedure but as long as you follow the instructions given to you such as eating plenty before you have it done, you will be fine afterwards and the pain while it is being carried out is minimal.

Bone marrow transplant is different to the other two types of donation as you can sign up from the age of 17 but only 1 in 1000 donors will ever need to make a donation, this is because you are donating the stem cells in your bone marrow and it is unlikely that someone you match will need it. However if you do get called up one day and asked to donate it is a great feeling knowing that you alone have saved someone's life so easily, with just a procedure similar to blood donation.

If you're interested in becoming a donor just have a look at organdonation.nhs.uk, blood.co.uk or the Anthony Nolan trust website.

Also I am looking forward to the Oxford study day that I'm going to next Wednesday, I hope I find it worthwhile and I'll be reporting back next week.

Jack

Wednesday, 29 February 2012

Compassion important in care

Whether it's medical or social, in a hospital or an old people's home it's obvious that compassion towards the people in your care is vital. When recruiting doctors and nurses it is important that they have a good bedside manner, especially with elderly patients and it is crucial for prospective doctors to be compassionate and sympathetic.

With all the current medical advances in recent times a lot more people are living into their 80s and beyond which is great but it is an increasing burden on the NHS. However just having a pleasant manner towards your patients, treating them as people rather than just a collection of symptoms and taking the time to speak to them can make an immeasurable improvement to the quality of their lives, not to mention making yourself feel more content in your job, knowing that they've left your care happy.

If I manage to become a doctor I hope that I remember to look out for the psychological and emotional wellbeing of my patients as well as their physical health because it's something that no true doctor is complete without. Even with the long shifts and stressful situations you encounter it doesn't take much just to put on a smile for your patients, and it might make you feel a little bit better as well.

Jack

Friday, 24 February 2012

Oxford University/Gender abortions

Good news! This week I was accepted to go to Oxford University on March 14th for a study day in medicine that I applied to about a month ago. I'm looking forward to having a look around the university which I haven't visited before and learning a little more about studying medicine from the undergraduates themselves. Overall it will be a good experience and help me to plan ahead with my career.

I am also yet to hear from Nottingham university about their summer residential which will give me an insight into university life outside of the lecture theatre like the Medlink programme did.

On a more downbeat note it has been reported in the press this week that doctors have been performing abortions on patients solely because they didn't like the gender of their unborn child. A shocking piece of news that acts as a reminder of why doctors need to remain wary of the ethical implications surrounding their work.

I also find it disappointing on the parents' part as a woman's pregnancy should be treasured no matter what the gender of child and an abortion should not even enter their mind when they find out. If the child will almost certainly suffer from a critical disability? Possibly, but if you'd rather have the other gender? Certainly not.

I appreciate that the mothers may see it as necessary in cases concerning rape or where they will be unable to cope but this is taking it too far and the doctors involved have lost sight of why they joined the profession in the first place.

Jack

Friday, 17 February 2012

Stem cells and gene therapy join forces to restore organ function

Whilst doing some research for Human Biology this week I came across an article about how scientists at the university of Cambridge were working on a possible alternative to transplants.

They were able to correct the faulty gene in the DNA of a stem cell and then turn it into a fully functioning liver cell, to do this a molecular scalpel was used to cut out the faulty allele and insert the correct one. To patients with liver cirrhosis this could mean a new organ without the need for transplantation, saving lives and cutting the demand for donors.

However there are fears about the procedure as artificially induced stem cells may be vulnerable to expressing cancer causing genes.

Friday, 10 February 2012

Jaw transplant made by 3D printer!

A few days ago I read the fascinating story of how a woman in the Netherlands received an artificial jaw which was created by a 3D printer!

The operation, carried out on an 83 year old woman from the Netherlands last June was the first of it's kind. The jaw was able to match perfectly to the patient as it had been specifically tailored to her, thanks to it being made via a laser one layer at a time and then given a bioceramic coating.

The jaw is a sophisticated piece of technology as it has articulated joints, grooves to direct the regrowth of nerves and veins and cavities to promote muscle attachment.

This type of surgery has advantages over traditional reconstructive surgery because it only took four hours to carry out, which may sound a lot but is only a fifth of the time required for traditional surgery. This can only be a good thing as it reduces the stress on the patient and the amount of time they need to be hospitalised for, reducing the costs to the NHS.

Hopefully then these sorts of procedures will become more commonplace over the coming years and the technology may even advance enough to spread out into the realm of artificial organs such as the heart and lungs!

Jack

Friday, 3 February 2012

Heart Disease/ University experience

This week in Human Biology we've been learning a bit more about how blockages in the coronary artery form. It turns out that it actually occurs as a result of the body's own defences, this happens by phagocytes clearing up cholesterol in the artery but by doing this they become foam cells which forms the blockage and hardens into plaque.

On a different note this week I applied to the University of Nottingham experience program for the 'Medicine and Health Sciences' category which I hope to get onto. If anyone is interested it is taking place from 8-13 July and your school/college may tell you about it soon. And it's free!

Jack

Thursday, 26 January 2012

Journey to medical school

Hi my name is Jack and my ambition is to get into medical school and become a doctor. I've set up this blog so I can share my thoughts with other like minded people and talk a little about medicine in the news as it happens.

So what's happening at the moment??

Well I've recently read an article from BBC news claiming that the number of deaths in England caused by heart attacks has halved in the past decade. In a research study by Oxford University which uncovered this they found that this was partly due to fewer heart attacks taking place and partly due to a lower number of these heart attacks being fatal. The researchers praised the NHS for better prevention measures which have led to a lower number of patients winding up in the position where they suffer a heart attack.

I have also been learning about this recently in Human Biology and have been looking at some of the treatments that can be given to people that have already suffered a heart attack. The one I found most interesting out of the ones we studied is stenting. This is where a blockage in the coronary artery is cleared by inserting a stent to compress the plaque against the artery wall and widen the lumen of the artery. As well as this we looked at bypass surgery where the blood is rerouted around the blockage through a new blood vessel, made by taking a small part of the saphenous vein from the leg, this then means that blood can reach the area of the heart which was previously starved of oxygen and nutrients. However one thing that no one in my class could work out wad what then happens to the saphenous vein after a part has been removed? So if anyone knows the answer to that I'd be very grateful if you could share it.

Ok so that's all for this first post but I'll be back soon with more from the world of medicine and my efforts to be a part of it.

Thanks for reading,

Jack